<DOC>
	<DOCNO>NCT00703391</DOCNO>
	<brief_summary>The purpose study assess tolerability ( effect drug body ) pharmacokinetics ( effect body drug ) AZD9668 patient mild moderate COPD</brief_summary>
	<brief_title>A Two Week Study Assess Tolerability AZD9668 Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Mild moderate COPD Smokers exsmokers postmenopausal female Past history current evidence clinically significant heart disease Lung disease COPD Treatment systemic steroid within 8 week study visit 2 Treatment antibiotic within 4 week study visit 1 study visit 2</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Chronic</keyword>
	<keyword>obstructive</keyword>
	<keyword>pulmonary</keyword>
	<keyword>lung</keyword>
	<keyword>respiratory disease</keyword>
	<keyword>tolerability</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>COPD</keyword>
</DOC>